IUGNFImugene, Ltd.

About Imugene, Ltd. (IUGNF)

Imugene, Ltd. (IUGNF) is a Biotechnology company headquartered in Sydney, NSW, Australia whose shares trade over-the-counter on the Pink tier.

Imugene is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors.

IUGNF key facts

Ticker symbol

IUGNF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Sydney, NSW, Australia

Country of incorporation

AU

Estimated market cap

$90.94M (as of Apr 11, 2025)

Shares outstanding

4,663,540,972

Reporting standard

International Reporting: ASX - Australian Securities Exchange

Audit status

Audited

Fiscal year end

6/30

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with I